These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21630510)

  • 1. Synthesis of novel basic skeletons derived from naltrexone.
    Nagase H; Fujii H
    Top Curr Chem; 2011; 299():187-237. PubMed ID: 21630510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of novel triplet drugs with 1,3,5-trioxazatriquinane skeletons and their pharmacologies. 1: Synthesis of triplet drugs with morphinan skeletons.
    Nagase H; Watanabe A; Nemoto T; Nakajima M; Hasebe K; Mochizuki H; Fujii H
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4023-6. PubMed ID: 21641219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel synthesis of a 1,3,5-trioxazatriquinane skeleton using a nitrogen clamp.
    Nagase H; Watanabe A; Harada M; Nakajima M; Hasebe K; Mochizuki H; Yoza K; Fujii H
    Org Lett; 2009 Feb; 11(3):539-42. PubMed ID: 19115979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses of 4,6'-epoxymorphinan derivatives and their pharmacologies.
    Nemoto T; Fujii H; Narita M; Miyoshi K; Nakamura A; Suzuki T; Nagase H
    Bioorg Med Chem; 2008 Apr; 16(8):4304-12. PubMed ID: 18337104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of N-isobutylnoroxymorphone from naltrexone by a selective cyclopropane ring opening reaction.
    Fujii H; Osa Y; Ishihara M; Hanamura S; Nemoto T; Nakajima M; Hasebe K; Mochizuki H; Nagase H
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4978-81. PubMed ID: 18755589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel delta opioid receptor agonists and their pharmacologies.
    Nagase H; Osa Y; Nemoto T; Fujii H; Imai M; Nakamura T; Kanemasa T; Kato A; Gouda H; Hirono S
    Bioorg Med Chem Lett; 2009 May; 19(10):2792-5. PubMed ID: 19362480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, opioid receptor binding, and functional activity of 5'-substituted 17-cyclopropylmethylpyrido[2',3':6,7]morphinans.
    Ananthan S; Kezar HS; Saini SK; Khare NK; Davis P; Dersch CM; Porreca F; Rothman RB
    Bioorg Med Chem Lett; 2003 Feb; 13(3):529-32. PubMed ID: 12565965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological properties of bivalent ligands containing butorphan linked to nalbuphine, naltrexone, and naloxone at mu, delta, and kappa opioid receptors.
    Peng X; Knapp BI; Bidlack JM; Neumeyer JL
    J Med Chem; 2007 May; 50(9):2254-8. PubMed ID: 17407276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of substitution on the pyrrole N atom in derivatives of tetrahydronaltrindole, tetrahydrooxymorphindole, and a related 4,5-epoxyphenylpyrrolomorphinan.
    Srivastava SK; Shefali S; Miller CN; Aceto MD; Traynor JR; Lewis JW; Husbands SM
    J Med Chem; 2004 Dec; 47(26):6645-8. PubMed ID: 15588100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 14-Amino-4,5-epoxymorphinan derivatives and their pharmacological actions.
    Lewis JW; Husbands SM
    Top Curr Chem; 2011; 299():93-119. PubMed ID: 21630516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities.
    Portoghese PS; Larson DL; Sayre LM; Fries DS; Takemori AE
    J Med Chem; 1980 Mar; 23(3):233-4. PubMed ID: 6245210
    [No Abstract]   [Full Text] [Related]  

  • 12. Naltrindole 5'-isothiocyanate: a nonequilibrium, highly selective delta opioid receptor antagonist.
    Portoghese PS; Sultana M; Takemori AE
    J Med Chem; 1990 Jun; 33(6):1547-8. PubMed ID: 2160532
    [No Abstract]   [Full Text] [Related]  

  • 13. A remarkable change of opioid receptor selectivity on the attachment of a peptidomimetic kappa address element to the delta antagonist, natrindole: 5'-[N2-alkylamidino)methyl]naltrindole derivatives as a novel class of kappa opioid receptor antagonists.
    Olmsted SL; Takemori AE; Portoghese PS
    J Med Chem; 1993 Jan; 36(1):179-80. PubMed ID: 8380614
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and evaluation of novel opioid ligands with a C-homomorphinan skeleton.
    Ishikawa K; Mochizuki Y; Hirayama S; Nemoto T; Nagai K; Itoh K; Fujii H
    Bioorg Med Chem; 2016 May; 24(10):2199-205. PubMed ID: 27079125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereospecific synthesis of the 6beta-hydroxy metabolites of naltrexone and naloxone.
    Chatterjie N; Inturrisi CE
    J Med Chem; 1975 May; 18(5):490-2. PubMed ID: 1151958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transformation of naltrexone into mesembrane and investigation of the binding properties of its intermediate derivatives to opioid receptors.
    Konoura K; Fujii H; Imaide S; Gouda H; Hirayama S; Hirono S; Nagase H
    Bioorg Med Chem; 2015 Feb; 23(3):439-48. PubMed ID: 25573119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid agonist and antagonist activities of morphindoles related to naltrindole.
    Portoghese PS; Larson DL; Sultana M; Takemori AE
    J Med Chem; 1992 Nov; 35(23):4325-9. PubMed ID: 1333013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Activity Relationships of (+)-Naltrexone-Inspired Toll-like Receptor 4 (TLR4) Antagonists.
    Selfridge BR; Wang X; Zhang Y; Yin H; Grace PM; Watkins LR; Jacobson AE; Rice KC
    J Med Chem; 2015 Jun; 58(12):5038-52. PubMed ID: 26010811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of Beckett-Casy model 1: synthesis of novel 16,17-seco-naltrexone derivatives and their pharmacology.
    Imaide S; Fujii H; Watanabe A; Nemoto T; Nakajima M; Nakao K; Mochizuki H; Nagase H
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1055-8. PubMed ID: 20056539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.